Schmitz, M., Villar-Piqué, A., Hermann, P., Escaramís, G., Calero, M., Chen,C., Kruse, N., Cramm, M., Golanska, E., Sikorska, B., Liberski, P. P., Pocchiari, M., Lange,P., Stehmann, C., Sarros, S., Martí, E., Baldeiras, I., Santana, I., Zákova, D., Mitrová, E., Dong, X.P., Collins, S., Poleggi, A., Ladogana, A., Mollenhauer, B., Kovacs, G.G., Geschwind, M. D., Sánchez-Valle, R., Zerr, I., Llorens, F., Diagnostic accuracy and prognostic utility of CSF biomarkers in genetic prion diseases. Brain (2022) Accepted https://doi.org/10.1093/brain/awab350
Matamoros-Angles, A., Hervera, A., Soriano, J., Marti, E., Carulla, P., Llorens, F., Nuvolone, M., Aguzzi, A., Ferrer, I., Gruart, A., Delgado-García, J. M., del Rio, J. A. Analysis of co-isogenic prion protein deficient mice reveals behavioral deficits, learning impairment, and enhanced hippocampal excitability. BMC Biology 2022 Jan 13;20(1): 17. doi: 10.1186/ s12915-021-01203-0. PMID: 35027047
Torres, A. G. & Martí, E. Toward an Understanding of Extracellular tRNA Biology. 2021 Apr 15;8: 662620. doi: 10.3389/ fmolb.2021.662620. eCollection 2021. PMID: 33937338
Creus-Muncunill J, Guisado-Corcoll A, Venturi V, Pantano L, Escaramís G, García de Herreros M, Solaguren-Beascoa M, Gámez-Valero A, Navarrete C, Masana M, Llorens F, Diaz-Lucena D, Pérez-Navarro E, Martí E. Huntington's disease brain-derived small RNAs recapitulate associated neuropathology in mice. Acta Neuropathol. 2021 Feb 6. doi: 10.1007/ s00401-021- 02272-9. PMID: 33547932
Gamez-Valero A, Guisado-Corcoll A, Herrero-Lorenzo M, Solaguren-Beascoa M, Martí E. Non-coding RNAs as sensors of Oxidative Stress in Neurodegeneerative Diseases, Antioxidants (Basel) 2020 Nov 8;9 (11): 1095. doi: 10.3390/ antiox9111095. PMID: 33171576
Vives-Usano M, (26 authors), Martí E, Vrijheid M, Bustamante M. In utero and childhood exposure to tobacco smoke and multi-layer molecular signatures in children BMC Med. 2020 Aug 19;18(1): 243. doi: 10.1186/ s12916-020- 01686-8. PMID: 32811491
Pallarès-Albanell J, Zomeño-Abellán MT, Escaramís G, Pantano L, Soriano A, Segura MF, Martí E. A High-Throughput Screening Identifies MicroRNA Inhibitors That Influence Neuronal Maintenance and/or Response to Oxidative Stress. Molecular Therapy Nucleic Acids, Sep 6;17:374-387. doi: 10.1016/ j.omtn.2019.06.007. Epub 2019 Jun 20. PMID: 31302497
Diaz Lucena D; Escaramís G, Villar-Piqué A, Hermann P, Schmitz M, Varges D, Santana I, del Rio JA, Martí E, Ferrer i, Baldeiras i, Zerr i. A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia. J of Neurology, Sep;267(9): 2567-2581. doi: 10.1007/ s00415-020- 09870-9. Epub 2020 May 5. PMID: 32372181
Pantano L, Pantano F, Marti E, Ho Sui S. Visualization of the small RNA transcriptome using seqclusterViz. F1000Res. 2019 Feb 28;8. pii: ISCB Comm J-232. doi: 10.12688 /f1000research. 18142.1. eCollection 2019. PMID: 30984380
Llorens F, Thüne K, Martí E, Kanata E, Dafou D, Díaz-Lucena D, Vivancos A, Shomroni O, Zafar S, Schmitz M, Michel U, Fernández-Borges N, Andréoletti O, Del Río JA, Díez J, Fischer A, Bonn S, Sklaviadis T, Torres JM, Ferrer I, Zerr I. Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis. PLoS Pathog. 2018 Jan 22;14(1): e1006802. doi: 10.1371/ journal.ppat.1006802. eCollection 2018 Jan. PMID: 29357384
Pagès A, Dotu I, Pallarès-Albanell J, Martí E, Guigó R, Eyras E. The discovery potential of RNA processing profiles. Nucleic Acids Res. 2018 Feb 16;46 (3):e15. doi: 10.1093 /nar/gkx1115. PMID: 29155959
Llorens F, Thüne K, Andrés-Benito P, Tahir W, Ansoleaga B, Hernández-Ortega K, Martí E, Zerr I, Ferrer I. MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology. J Mol Neurosci. 2017 Oct;63(2):206-215. doi: 10.1007/s12031-017-0971-4. Epub 2017 Sep 5. PMID: 28871468
Rué L, Bañez-Coronel M, Creus-Muncunill J, Giralt A, Alcalá-Vida R, Mentxaka G, Kagerbauer B, Zomeño-Abellán MT, Aranda Z, Venturi V, Pérez-Navarro E, Estivill X, Martí E. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. J Clin Invest. 2016 Nov 1;126 (11): 4319-4330. doi: 10.1172/ JCI83185. Epub 2016 Oct 10. PMID: 27721240
Martí E. RNA toxicity induced by expanded CAG repeats in Huntington's disease. Brain Pathol. 2016 Nov;26 (6): 779-786. doi: 10.1111/ bpa.12427. Review. PMID: 27529325
Pantano L, Friedländer MR, Escaramís G, Lizano E, Pallarès-Albanell J, Ferrer I, Estivill X, Martí E. Specific small-RNA signatures in the amygdala at premotor and motor stages of Parkinson's disease revealed by deep sequencing analysis. Bioinformatics. 2016 Mar 1;32 (5): 673-81. doi: 10.1093/ bioinformatics/ btv632. Epub 2015 Nov 2. PMID: 26530722
Friedländer MR, Lizano E, Houben AJ, Bezdan D, Báñez-Coronel M, Kudla G, Mateu-Huertas E, Kagerbauer B, González J, Chen KC, LeProust EM, Martí E, Estivill X. Evidence for the biogenesis of more than 1,000 novel human microRNAs.Genome Biol. 2014 Apr 7;15(4): R57. doi: 10.1186/ gb-2014-15-4-r57. PMID: 24708865
Mateu-Huertas E, Rodriguez-Revenga L, Alvarez-Mora MI, Madrigal I, Willemsen R, Milá M, Martí E*, Estivill X* (co-corresponding). Blood expression profiles of fragile X premutation carriers identify candidate genes involved in neurodegenerative and infertility phenotypes. Neurobiol Dis. 2014 May; 65:43-54. doi: 10.1016 /j.nbd.2013.12.020. Epub 2014 Jan 10. PMID: 24418349
Martí E*, Estivill X*. (co-corresponding) Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases. Front Mol Neurosci. 2013 Dec 3;6: 45. doi: 10.3389/ fnmol.2013.00045. Review. PMID: 24348326
Aigner J, Villatoro S, Rabionet R, Roquer J, Jiménez-Conde J, Martí E, Estivill X. A Common 56-kilobase Deletion in a Primate-Specific Segmental Duplication Creates a Novel Butyrophilin-Like Protein BMC Genetics. BMC Genet. 2013 Jul 6;14:61. doi: 10.1186/ 1471-2156-14-61. PMID: 23829304
Llorens F, Hummel M, Pantano L, Pastor X, Vivancos A, Castillo E, Mattlin H, Ferrer A, Ingham M, Noguera M, Kofler R, Dohm JC, Pluvinet R, Bayés M, Himmelbauer H, del Rio JA, Martí E, Sumoy L. Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor. BMC Genomics. 2013 Jun 1;14:371. doi: 10.1186/ 1471-2164-14-371. PMID: 23724959
Alvarez-Mora MI, Rodriguez-Revenga L, Madrigal I, Torres-Silva F, Mateu-Huertas E, Lizano E, Friedlander M, Martí E, Estivill X, Milà M. MicroRNA expression profiling in blood from fragile X-associated tremor/ataxia syndrome patients. Genes Brain Behav. 2013 Aug;12(6): 595-603. doi: 10.1111/ gbb.12061. Epub 2013 Jul 24.
Miñones-Moyano E., Friedländer MR, Pallarés J, Kagerbauer B, Porta S, Escaramís G, Ferrer I, Estivill X, Martí E. Upregulation of a small vault RNA (svRNA2-1a) is an early event in Parkinson’s disease and induces neuronal dysfunction. RNA Biol. 2013 Jul;10(7): 1093-106. doi: 10.4161/ rna.24813. Epub 2013 May 1. PMID: 23673382
Llorens F, Bañez-Coronel M, del Río JA, Ferrer I, Estivill X, Martí E. A highly expressed miR-101 isomiR is a functional silencing small RNA. BMC Genomics. 2013 Feb 15;14: 104. doi: 10.1186/ 1471-2164-14-104. PMID: 23414127
Bañez-Coronel M, Porta S, Kagerbauer B, Mateu E, Pantano L, Ferrer I, Guzmán M, Estivill X & Martí E. A pathogenic mechanism in Huntington’s disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet. 2012;8(2): e1002481. doi: 10.1371/ journal.pgen.1002481. Epub 2012 Feb 23. PMID: 22383888
